Wave Life Sciences Ltd.
WVE | NASDAQ
$4.25
$0 (-0.12%)
Sep 22, 2026, 10:48 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 42.73M | 108.3M | 113.31M | 3.65M | 40.96M | 20.08M |
Cost of Revenue | 8.85M | n/a | n/a | n/a | n/a | 130.94M |
Gross Profit | 33.88M | 108.3M | 113.31M | 3.65M | 40.96M | -110.87M |
Operating Income | -215.38M | -110.4M | -68M | -162.72M | -127.02M | -153.38M |
Interest Income | 10.48M | n/a | n/a | n/a | 30K | n/a |
Pretax Income | -204.38M | -97.01M | -58.19M | -161.14M | -122.45M | -150.75M |
Net Income | -204.38M | -97.01M | -57.51M | -161.82M | -122.25M | -149.91M |
Selling & General & Admin | 75.33M | 59.02M | 51.29M | 50.51M | 46.11M | 42.51M |
Research & Development | 182.78M | 159.68M | 130.01M | 115.86M | 121.88M | 130.94M |
Other Expenses | -8.85M | n/a | n/a | n/a | n/a | -130.94M |
Operating Expenses | 249.26M | 218.71M | 181.3M | 166.37M | 167.98M | 42.51M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 16K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 258.11M | 218.71M | 181.3M | 166.37M | 167.98M | 173.45M |
Income Tax Expense | n/a | n/a | -677K | 681K | -204K | -841K |
Shares Outstanding (Basic) | 168.65M | 138.28M | 106.1M | 78.86M | 51.83M | 39.23M |
Shares Outstanding (Diluted) | 168.65M | 138.28M | 106.1M | 78.86M | 51.83M | 39.23M |
EPS (Basic) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 |
EPS (Diluted) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 |
EBITDA | -195.53M | -88.35M | -48.98M | -151.03M | -112.61M | -145.26M |
EBIT | -204.38M | -97.01M | -58.19M | -161.14M | -122.45M | -153.38M |
Depreciation & Amortization | 8.85M | 8.66M | 9.21M | 10.11M | 9.84M | 8.11M |
Add to Watchlist
Select watchlists to add or remove WVE